As a mid-career employee, I’ve earned expertise in many areas but feel I still have much to learn. More importantly, I feel have much left to offer.

Danielle Gabrish is the Director of Clinical Biologics at AstraZeneca and the Chair of the ISPE Women in Pharma^® group for ISPE’s Chesapeake Bay Chapter. She’s also a mom, mentor, and advocate for women and Emerging Leaders.

You may have already read through our Members Guide to ISPE’s 2023 Annual Meeting & Expo, which offers a high-level overview of all the conference highlights. Within this article, we’ll break down the various Women in Pharma® activities scheduled throughout the meeting. From an empowering self-defense class to a nostalgic...

Addressing the unmet healthcare & medical needs is among the top priorities for global governments and organisations, including the pharmaceutical industry. We are facing unprecedented challenges due to the change with medical knowledge doubling every 72 days1

Shanghai ISPE Pharmaceutical Information Company (SPIC) held the 2023 Global Biopharma Engineering Forum and ISPE China Conference in Hangzhou, China on 26-27, May 2023. Mr. Ping Zhang, Chairman of SPIC and the ISPE China Committee, introduced ISPE and provided an in-depth analysis of the prospects of domestic and foreign bio-pharmaceutical enterprises. The in-depth discussions from this...

Facility of the Year Award (FOYA) Winners in the Innovation category exemplify the application of novel manufacturing processes, innovative design concepts, new technologies, and unique solutions that...

Cloud-based systems for plant process management (PPM)1

Facility of the Year Award (FOYA) Winners in the Operations category exemplify the application of novel tools and approaches to delivering projects that improved efficiencies, overcame unusual challenges,...

Building off of the success of the 2022 ISPE Annual Meeting & Expo, the 2023 ISPE Annual Meeting & Expo Program Committee has developed a robust Workshop program covering key areas in Digital Transformation (DT) and Pharma 4.0™, Quality Risk Management (QRM), Contamination Control Strategy (CCS) and Annex 1, Facility...

Data Governance is currently utilized in many areas of business and government including finance, banking, telecommunications, and by the agencies regulating these industries. In pharmaceuticals, digital validation is still at a relatively early stage of the digital transformation journey where data governance is currently managed in silos of data (Industry 3.0) and the industry has of yet to...

Pharmaceutical Engineering^® is delighted to announce the finalists for the 2022 Roger F. Sherwood Article of the Year Award. The articles were selected by judges of 36 feature and...

Opening the 2023 ISPE Europe Annual Conference on 8 May, Peter Twomey, Head of Inspections for the European Medicines Agency (EMA), offered a keynote address titled International Cooperation, Harmonization, and Reliance in GMP.

In the beautiful city of Barcelona, Spain, ISPE will host members, vendors, pharmaceutical companies, consulting firms, and design companies for the 2023 ISPE Pharma 4.0™ and Annex 1 Conference on...

Emer Cooke, Executive Director of the European Medicines Agency (EMA), delivered an impactful keynote address at the 2023 ISPE Europe Annual Conference, held 8-10 May , in Amsterdam, The Netherlands. Cooke...

Tracy Jamerson is the Chapter Manager for the ISPE Midwest Chapter. She brings 10+ years of experience to the pharmaceutical industry, currently working as the Office Coordinator at Compli, - a wholly-owned subsidiary of George Butler Associates. Compli is part of the Life Sciences Division. GBA is multi-disciplinary. In this role, she is responsible for a variety of duties, including Project...

The 2023 ISPE Annual Meeting & Expo is just around the corner, taking place at Mandalay Bay in Las Vegas, NV from the 15th to the 18th of October 2023. As a distinguished member of the pharmaceutical...

I have been active in ISPE for many, many years, but when I attended my first ISPE Pharma 4.0™ and Annex 1 Conference in Manchester back in 2019, I was surprised by how few people I knew. I realized that my network within ISPE was very much focussed on Aseptic, Manufacturing, and Quality, and not so much on Digitalization and Pharma 4.0™.

The global pharmaceutical industry has faced unprecedented challenges in recent years, with the COVID-19 pandemic serving as a wake-up call for the vulnerabilities within the pharmaceutical supply chain. As the world strives to emerge from the grip of the pandemic and restore activities reminiscent of pre-pandemic times, uncertainties surrounding supply chain stability persist. The